TOP NEWS BioNTech/Pfizer expect new variant impact data 'within 2 weeks' Germany's BioNTech said Friday it was urgently studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa. AFP Read More
COVID-19: Dec 1 deadline: Only 3% eligible Nigerians fully vaccinated Joseph Onyekwere (Deputy Editor) and Nkechi Onyedika-Ugoeze (Abuja) Read More
Ahead G20 summit, ILO, others demand COVID-19 ‘vaccine justice’ Tope Templer Olaiya (News Editor) and Collins Olayinka (Abuja) Read More
Kaduna joins FG, Edo, Ondo to bar unvaccinated civil servants from offices Chukwuma Muanya (Deputy Editor, Health) Read More
COVID-19: Virologist advises FG against Dec. 1 deadline for vaccination of civil servants NAN Read More
Sanwo-Olu advocates COVID-19 vaccine equity at global citizen live concert Tope Templer Olaiya Read More